New ASCO Guidelines Recommending Aromasin to Lower Risk of Breast Cancer in High-Risk Postmenopausal Women

On July 8th, 2013, The American Society of Clinical Oncology (ASCO) released new guidelines recommending the horomonal therapy medicine Aromasin to lower the breast cancer risk in postmenopausal women who are considered at high-risk of developing the disease. This is big news in the breast cancer world. What and why, you wonder?  Well, I thought… Continue reading New ASCO Guidelines Recommending Aromasin to Lower Risk of Breast Cancer in High-Risk Postmenopausal Women

A Drug Holiday

A Drug Holiday About three weeks ago, I made a pretty radical decision: I decided to take a “drug holiday” from Tamoxifen. As you may recall, I was taking Tamoxifen because it is the typically-prescribed endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre-menopausal women (which describes me to a “T”). The net-net is that Tamoxifen has been shown to reduce… Continue reading A Drug Holiday